Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2020 | 12-2019 | 12-2018 | |
| Sales | 44,574 | 0 | 0 |
| Cost of Goods | 32,620 | N/A | N/A |
| Gross Profit | 11,954 | N/A | N/A |
| Operating Expenses | 29,558 | 0 | 0 |
| Operating Income | -16,984 | N/A | N/A |
| Other Income | -13,770 | 0 | 0 |
| Pre-tax Income | -30,754 | 0 | 0 |
| Income Tax | -1,857 | N/A | N/A |
| Net Income Continuous | -28,897 | N/A | N/A |
| Net Income | $-28,897 | $N/A | $N/A |
| EPS Basic Total Ops | -0.95 | N/A | N/A |
| EPS Basic Continuous Ops | -0.94 | N/A | N/A |
| EPS Diluted Total Ops | -0.95 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.94 | N/A | N/A |
| EBITDA(a) | $3,760 | $N/A | $N/A |